SCHEMBL1171372

SCHEMBL1171372

COc1ccccc1OC(=O)Cc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.60
TDP1 Q9NUW8 2/20 0.60
ATM Q13315 1/20 0.60
TSHR P16473 1/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
MAPK1 P28482 2/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C19 P33261 1/20 0.54
ALDH1A1 P00352 5/20 0.53
MAPT P10636 3/20 0.53
KMT2A Q03164 2/20 0.53
MEN1 O00255 1/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
HPGD P15428 1/20 0.52
POLB P06746 1/20 0.51
LMNA P02545 2/20 0.50
ALOX5 P09917 1/20 0.49
THRB P10828 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30233793 1.00 L3MBTL1 (0.60) L3MBTL1TDP1ATMTSHRSMN1; SMN2
SCHEMBL10573912 0.91 MAPK1 (0.61) L3MBTL1TDP1ATMTSHRSMN1; SMN2
SCHEMBL31321656 0.88 L3MBTL1 (0.64) L3MBTL1TDP1ATMSMN1; SMN2CYP1A2
SCHEMBL31321610 0.88 L3MBTL1 (0.60) L3MBTL1TDP1ATMTSHRSMN1; SMN2
SCHEMBL31321703 0.88 L3MBTL1 (0.78) L3MBTL1TDP1ATMSMN1; SMN2MAPK1
SCHEMBL31321640 0.87 L3MBTL1 (0.58) L3MBTL1TDP1ATMSMN1; SMN2ALDH1A1
SCHEMBL13524217 0.85 L3MBTL1 (0.57) L3MBTL1TDP1ATMTSHRCYP1A2
SCHEMBL4643953 0.83 MAPT (0.57) L3MBTL1TDP1ATMSMN1; SMN2CYP1A2
SCHEMBL31321692 0.83 L3MBTL1 (0.57) L3MBTL1TDP1ATMTSHRSMN1; SMN2
SCHEMBL28283295 0.83 AKR1C3 (0.64) L3MBTL1TDP1ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110483253-B Method for preparing guaiacol product by pyrolyzing lignin through steam-assisted fixed bed 中国林业科学研究院林产化学工业研究所 2022-05-06 CN claimed
CN-112868647-A Application of perfume compound in preparation of sanitary articles for inhibiting infection of novel coronavirus 广西壮族自治区中国科学院广西植物研究所 2021-06-01 CN claimed
EP-3809876-A1 PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME PERPRIN S.R.L. (IT) 2021-04-28 EP claimed
WO-2019243869-A1 PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME PERPRIN S.R.L. (IT) 2019-12-26 WO claimed
JP-4739231-B2 2011-08-03 JP claimed
EP-1716159-B1 BICYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS MOMENTIVE PERFORMANCE MAT INC (US) 2011-07-13 EP claimed
WO-2009131692-A1 SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2009-10-29 WO claimed
US-7579495-B2 Active-releasing cyclic siloxanes MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2009-08-25 US claimed
US-7576170-B2 Cyclic siloxane compositions for the release of active ingredients MOMENTIVE PERFORMANCE MATERIALS (US) 2009-08-18 US claimed
EP-1697386-B1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GEN ELECTRIC (US) 2007-10-10 EP claimed
EP-1716159-A2 CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS General Electronic Company (US) 2006-11-02 EP claimed
EP-1697386-A1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES General Electric Company A Corporation of the State of New York (US) 2006-09-06 EP claimed
WO-2005066187-A1 ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES GENERAL ELECTRIC COMPANY (US) 2005-07-21 WO claimed
WO-2005066186-A2 CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS GENERAL ELECTRIC COMPANY (US) 2005-07-21 WO claimed
US-20050136021-A1 Active-releasing cyclic siloxanes MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 US claimed
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients MOMENTIVE PERFORMANCE MATERIALS INC. 2005-06-23 US claimed
EP-4747001-A2 SILICA CAPSULES The Procter & Gamble Company (US) 2026-05-27 EP disclosed
US-12478942-B2 Methods of making capsules THE PROCTER & GAMBLE COMPANY (US) 2025-11-25 US disclosed
US-5800897-A Air freshener composition containing a fiber pad EASTMAN CHEMICAL COMPANY (US) 1998-09-01 US disclosed
WO-1997026926-A1 AIR FRESHENER COMPOSITION CONTAINING A FIBER PAD EASTMAN CHEMICAL COMPANY (US) 1997-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050136022-A1 Cyclic siloxane compositions for the release of active ingredients F9, RPL39, ECPAS L3MBTL1 1536/4885TDP1 3632/4885ATM 4132/4885
US-20050136021-A1 Active-releasing cyclic siloxanes F9, RPL39, ALDH16A1 L3MBTL1 1554/4885TDP1 3581/4885ATM 4518/4885
US-12478942-B2 Methods of making capsules FUT6, FUT5, LIPA L3MBTL1 4576/4885TDP1 4256/4885ATM 4319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.